Ticker

Ainos, Inc. (NASDAQ: AIMD - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 31st, there was short interest totaling 22,109 shares, a decline of 32.4% from the March 15th total of 32,693 shares. Based on an average trading volume of 26,195 shares, the

Expands AI Nose platform from industrial safety into clinical infrastructure HOUSTON, TX / ACCESS Newswire / April 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today announced a partnership with MacKay Memorial Hospital and Topco Scientific Co., Ltd. to deploy its AI Nose technology across high-risk hospital environments.

Report highlights transition to deployment-driven growth, with visible semiconductor rollout and early customer-backed revenue Smell AI, powered by AI Nose, is emerging as a new AI perception layer, supported by accelerating commercialization and expanding industrial adoption HOUSTON, TX / ACCESS Newswire / April 1, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today highlighted findings…

AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9% 2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financing HOUSTON, TX / ACCESS Newswire / March 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today reported financial results for the year ended December 31, 2025 and outlined commercialization momentum…

As AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industrial environments-positioning the Company at the forefront of this emerging category HOUSTON, TX / ACCESS Newswire / March 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform digitizing scent as a native data language for artificial intelligence, today highlighted its…